Foresight Diagnostics Expands Scientific Advisory Board with Appointment of Christopher R. Flowers, M.D., M.S.

Apr 27, 2022

Foresight Diagnostics today announced the appointment of Christopher R. Flowers, M.D., M.S., to its Scientific Advisory Board (SAB). Dr. Flowers is an oncologist specializing in the treatment of B cell lymphoma and rare subtypes of lymphoma. He currently serves as Chair and Professor in the Department of Lymphoma-Myeloma in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, TX, and is co-leader of MD Anderson’s B-Cell Lymphoma Moon Shot® program. Dr. Flowers takes an individualized approach to patient care by using molecular tests to identify unique cancer markers and tailoring treatment strategies specific to each patient. His involvement in many of the B cell lymphoma clinical trials at MD Anderson places him at the forefront of progress in the treatment of lymphoma…

Read the full article on PR Newswire.


Share this page on social

Ready to get started? See what Samba can do for you.